{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:48Z","timestamp":1792425648114,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umea University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Antidepressant use, which targets intracerebral serotonin metabolism, is common among glioblastoma patients. However, its interaction with tumor metabolism and survival remains unclear. We investigated the relationships between antidepressant use, intratumoral serotonin pathway metabolites, quality-of-life, and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analysed two complementary cohorts: a population-based cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009801) and a hospital-based biobank cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009153). In the population-based cohort, information about antidepressant use and survival were obtained from national registers. In the hospital-based cohort, intratumoral serotonin pathway metabolites were measured, and data on preoperative antidepressant use and quality-of-life were recorded. Linear and Cox regression models were used to investigate the association between antidepressant use, metabolites, quality-of-life and survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the population-based cohort, antidepressant use was associated with poorer survival in adjusted analyses. However, use of fluoxetine or sertraline was associated with better survival compared with other selective serotonin reuptake inhibitors (HR\u2009=\u20090.62, 95% CI\u2009=\u20090.44\u20130.88). In the hospital-based cohort, preoperative antidepressant use was associated with lower intratumoral serotonin levels and its downstream metabolite, 5-HIAA. Higher serotonin levels were associated with better preoperative quality-of-life, especially general health. Serotonin pathway metabolites were not clearly associated with survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that higher tumor tissue serotonin abundance was associated with better patient-reported well-being but not with survival in gliobastoma. Survival differed across SSRI exposure groups, although causal interpretation is limited by the observational design. These findings do not provide strong evidence against the continued clinical use of sertraline or fluoxetine in glioblastoma patients when indicated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-026-05694-1","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:47:04Z","timestamp":1782852424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6169-5155","authenticated-orcid":false,"given":"Wendy Yi-Ying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Numan Hellquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Bj\u00f6rkblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard L.","family":"Sj\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"5694_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, Reifenberger G (2024) Glioma. Nat Rev Dis Primers 10:33. https:\/\/doi.org\/10.1038\/s41572-024-00516-y","journal-title":"Nat Rev Dis Primers"},{"key":"5694_CR2","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/aje\/kwae100","volume":"193","author":"C Malmberg","year":"2024","unstructured":"Malmberg C, Hellquist BN, Sadanandan SA, Sandstrom M, Wu WY, Bjorkblom B, Melin B, Sjoberg RL (2024) Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis. Am J Epidemiol 193:1592\u20131599. https:\/\/doi.org\/10.1093\/aje\/kwae100","journal-title":"Am J Epidemiol"},{"key":"5694_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh HS, Morishita W, Geraghty AC, Silverbush D, Gillespie SM, Arzt M, Tam LT, Espenel C, Ponnuswami A, Ni L, Woo PJ, Taylor KR, Agarwal A, Regev A, Brang D, Vogel H, Hervey-Jumper S, Bergles DE, Suva ML, Malenka RC, Monje M (2019) Electrical and synaptic integration of glioma into neural circuits. Nature 573:539\u2013545. https:\/\/doi.org\/10.1038\/s41586-019-1563-y","journal-title":"Nature"},{"issue":"Suppl 2","key":"5694_CR4","first-page":"123","volume":"36","author":"F Artigas","year":"2002","unstructured":"Artigas F, Nutt DJ, Shelton R (2002) Mechanism of action of antidepressants. Psychopharmacol Bull 36(Suppl 2):123\u2013132","journal-title":"Psychopharmacol Bull"},{"key":"5694_CR5","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA (2023) The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry 28:3243\u20133256. https:\/\/doi.org\/10.1038\/s41380-022-01661-0","journal-title":"Mol Psychiatry"},{"key":"5694_CR6","doi-asserted-by":"publisher","first-page":"37732","DOI":"10.1038\/s41598-025-25464-9","volume":"15","author":"WY Wu","year":"2025","unstructured":"Wu WY, Melin B, Bjorkblom B, Sjoberg RL (2025) Addressing the serotonin hypothesis of depression through analyses of genetics, methylation and metabolite variations in glioma patients. Sci Rep 15:37732. https:\/\/doi.org\/10.1038\/s41598-025-25464-9","journal-title":"Sci Rep"},{"key":"5694_CR7","doi-asserted-by":"publisher","first-page":"vdae181","DOI":"10.1093\/noajnl\/vdae181","volume":"6","author":"Y Ge","year":"2024","unstructured":"Ge Y, Cao Y, Wang Q, Wang Y, Ma W (2024) Impact of antidepressant use on survival outcomes in glioma patients: A systematic review and meta-analysis. Neurooncol Adv 6:vdae181. https:\/\/doi.org\/10.1093\/noajnl\/vdae181","journal-title":"Neurooncol Adv"},{"key":"5694_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/nop\/npad057","volume":"11","author":"S Edstrom","year":"2024","unstructured":"Edstrom S, Hellquist BN, Sandstrom M, Sadanandan SA, Bjorkblom B, Melin B, Sjoberg RL (2024) Antidepressants and survival in glioma-A registry-based retrospective cohort study. Neurooncol Pract 11:125\u2013131. https:\/\/doi.org\/10.1093\/nop\/npad057","journal-title":"Neurooncol Pract"},{"key":"5694_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/nop\/npad019","volume":"10","author":"PB van der Meer","year":"2023","unstructured":"van der Meer PB, Dirven L, Hertler C, Boele FW, Batalla A, Walbert T, Rooney AG, Koekkoek JAF (2023) Depression and anxiety in glioma patients. Neurooncol Pract 10:335\u2013343. https:\/\/doi.org\/10.1093\/nop\/npad019","journal-title":"Neurooncol Pract"},{"key":"5694_CR10","doi-asserted-by":"publisher","first-page":"vdaf075","DOI":"10.1093\/noajnl\/vdaf075","volume":"7","author":"Y Sun","year":"2025","unstructured":"Sun Y, Hamo M, Atchley T, Nabors B, Markert J, Estevez-Ordonez D (2025) The effect of antidepressants on glioblastoma survival: A systematic review and meta-analysis. Neurooncol Adv 7:vdaf075. https:\/\/doi.org\/10.1093\/noajnl\/vdaf075","journal-title":"Neurooncol Adv"},{"key":"5694_CR11","doi-asserted-by":"publisher","first-page":"109957","DOI":"10.1016\/j.celrep.2021.109957","volume":"37","author":"J Bi","year":"2021","unstructured":"Bi J, Khan A, Tang J, Armando AM, Wu S, Zhang W, Gimple RC, Reed A, Jing H, Koga T, Wong IT, Gu Y, Miki S, Yang H, Prager B, Curtis EJ, Wainwright DA, Furnari FB, Rich JN, Cloughesy TF, Kornblum HI, Quehenberger O, Rzhetsky A, Cravatt BF, Mischel PS (2021) Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep 37:109957. https:\/\/doi.org\/10.1016\/j.celrep.2021.109957","journal-title":"Cell Rep"},{"key":"5694_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41389-024-00540-3","volume":"13","author":"A Sanchez-Castillo","year":"2024","unstructured":"Sanchez-Castillo A, Savelkouls KG, Baldini A, Hounjet J, Sonveaux P, Verstraete P, De Keersmaecker K, Dewaele B, Bjorkblom B, Melin B, Wu WY, Sjoberg RL, Rouschop KMA, Broen MPG, Vooijs M, Kampen KR (2024) Sertraline\/chloroquine combination therapy to target hypoxic and immunosuppressive serine\/glycine synthesis-dependent glioblastomas. Oncogenesis 13:39. https:\/\/doi.org\/10.1038\/s41389-024-00540-3","journal-title":"Oncogenesis"},{"key":"5694_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11060-025-05288-3","volume":"176","author":"Y Sun","year":"2025","unstructured":"Sun Y, Hamo M, Atchley T, Markert JM, Nabors B, Estevez-Ordonez D (2025) Survival outcomes associated with antidepressant use in glioblastoma: a cohort study. J Neurooncol 176:47. https:\/\/doi.org\/10.1007\/s11060-025-05288-3","journal-title":"J Neurooncol"},{"issue":"Suppl 3","key":"5694_CR14","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/s0924-977x(99)00030-9","volume":"9","author":"DJ Nutt","year":"1999","unstructured":"Nutt DJ, Forshall S, Bell C, Rich A, Sandford J, Nash J, Argyropoulos S (1999) Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 9(Suppl 3):S81\u201386. https:\/\/doi.org\/10.1016\/s0924-977x(99)00030-9","journal-title":"Eur Neuropsychopharmacol"},{"key":"5694_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","volume":"113","author":"A Coppen","year":"1967","unstructured":"Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237\u20131264. https:\/\/doi.org\/10.1192\/bjp.113.504.1237","journal-title":"Br J Psychiatry"},{"key":"5694_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11060-019-03294-w","volume":"145","author":"RL Sjoberg","year":"2019","unstructured":"Sjoberg RL, Wu WY, Dahlin AM, Tsavachidis S, Gliogene G, Bondy ML, Melin B (2019) Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study. J Neurooncol 145:287\u2013294. https:\/\/doi.org\/10.1007\/s11060-019-03294-w","journal-title":"J Neurooncol"},{"key":"5694_CR17","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/neuonc\/nox210","volume":"20","author":"SP Caragher","year":"2018","unstructured":"Caragher SP, Hall RR, Ahsan R, Ahmed AU (2018) Monoamines in glioblastoma: complex biology with therapeutic potential. Neuro Oncol 20:1014\u20131025. https:\/\/doi.org\/10.1093\/neuonc\/nox210","journal-title":"Neuro Oncol"},{"key":"5694_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1476-5381.2010.00923.x","volume":"161","author":"RE Kast","year":"2010","unstructured":"Kast RE (2010) Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines. Br J Pharmacol 161:481\u2013487. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00923.x","journal-title":"Br J Pharmacol"},{"key":"5694_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2004.01.009","volume":"1002","author":"K Hisaoka","year":"2004","unstructured":"Hisaoka K, Nishida A, Takebayashi M, Koda T, Yamawaki S, Nakata Y (2004) Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res 1002:167\u2013170. https:\/\/doi.org\/10.1016\/j.brainres.2004.01.009","journal-title":"Brain Res"},{"key":"5694_CR20","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1158\/0008-5472.CAN-04-1600","volume":"64","author":"S Basu","year":"2004","unstructured":"Basu S, Sarkar C, Chakroborty D, Nagy J, Mitra RB, Dasgupta PS, Mukhopadhyay D (2004) Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor\/vascular endothelial growth factor-mediated angiogenesis. Cancer Res 64:5551\u20135555. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1600","journal-title":"Cancer Res"},{"key":"5694_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/s0306-4522(98)00693-9","volume":"89","author":"JM Brezun","year":"1999","unstructured":"Brezun JM, Daszuta A (1999) Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 89:999\u20131002. https:\/\/doi.org\/10.1016\/s0306-4522(98)00693-9","journal-title":"Neuroscience"},{"key":"5694_CR22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1080\/0284186X.2018.1497300","volume":"57","author":"O Sjostrom","year":"2018","unstructured":"Sjostrom O, Silander G, Syk I, Henriksson R, Melin B, Hellquist BN (2018) Disparities in colorectal cancer between Northern and SouthernSweden - a report from the new RISK North database. Acta Oncol 57:1622\u20131630. https:\/\/doi.org\/10.1080\/0284186X.2018.1497300","journal-title":"Acta Oncol"},{"key":"5694_CR23","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/neuonc\/noac042","volume":"24","author":"B Bjorkblom","year":"2022","unstructured":"Bjorkblom B, Wibom C, Eriksson M, Bergenheim AT, Sjoberg RL, Jonsson P, Brannstrom T, Antti H, Sandstrom M, Melin B (2022) Distinct metabolic hallmarks of WHO classified adult glioma subtypes. Neuro Oncol 24:1454\u20131468. https:\/\/doi.org\/10.1093\/neuonc\/noac042","journal-title":"Neuro Oncol"},{"key":"5694_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/sj.bjc.6605127","volume":"101","author":"J Dunn","year":"2009","unstructured":"Dunn J, Baborie A, Alam F, Joyce K, Moxham M, Sibson R, Crooks D, Husband D, Shenoy A, Brodbelt A, Wong H, Liloglou T, Haylock B, Walker C (2009) Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer 101:124\u2013131. https:\/\/doi.org\/10.1038\/sj.bjc.6605127","journal-title":"Br J Cancer"},{"key":"5694_CR25","doi-asserted-by":"publisher","first-page":"vdaf034","DOI":"10.1093\/noajnl\/vdaf034","volume":"7","author":"J Axelsson","year":"2025","unstructured":"Axelsson J, Bjorkblom B, Asklund T, Brandel J, Larhed S, Ringmar GM, Hedman K, Riklund K, Sjoberg RL, Sandstrom M (2025) Characterizing long- and short-survival glioblastoma patients with FLT-PET\/MRI and metabolomics. Neurooncol Adv 7:vdaf034. https:\/\/doi.org\/10.1093\/noajnl\/vdaf034","journal-title":"Neurooncol Adv"},{"key":"5694_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"JJ Schildkraut","year":"1965","unstructured":"Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509\u2013522. https:\/\/doi.org\/10.1176\/ajp.122.5.509","journal-title":"Am J Psychiatry"},{"key":"5694_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","volume":"23","author":"TM Hillhouse","year":"2015","unstructured":"Hillhouse TM, Porter JH (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1\u201321. https:\/\/doi.org\/10.1037\/a0038550","journal-title":"Exp Clin Psychopharmacol"},{"key":"5694_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1467-9450.2011.00891.x","volume":"52","author":"RL Sjoberg","year":"2011","unstructured":"Sjoberg RL, Blomstedt P (2011) The psychological neuroscience of depression: implications for understanding effects of deep brain stimulation. Scand J Psychol 52:411\u2013419. https:\/\/doi.org\/10.1111\/j.1467-9450.2011.00891.x","journal-title":"Scand J Psychol"},{"key":"5694_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00006842-199901000-00003","volume":"61","author":"LR Wulsin","year":"1999","unstructured":"Wulsin LR, Vaillant GE, Wells VE (1999) A systematic review of the mortality of depression. Psychosom Med 61:6\u201317. https:\/\/doi.org\/10.1097\/00006842-199901000-00003","journal-title":"Psychosom Med"},{"key":"5694_CR30","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1038\/s41598-024-65907-3","volume":"14","author":"A Jacquerie","year":"2024","unstructured":"Jacquerie A, Hoeben A, Eekers DBP, Postma AA, Vanmechelen M, de Smet F, Ackermans L, Anten M, Severens K, Zur Hausen A, Broen MPG, Beckervordersandforth J (2024) Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma. Sci Rep 14:14975. https:\/\/doi.org\/10.1038\/s41598-024-65907-3","journal-title":"Sci Rep"},{"key":"5694_CR31","doi-asserted-by":"publisher","first-page":"218318","DOI":"10.1016\/j.canlet.2026.218318","volume":"643","author":"Z Liu","year":"2026","unstructured":"Liu Z, Wan J, Liu S (2026) Bidirectional relationship between cancer and depression: From shared mechanisms to integrated therapeutic strategies. Cancer Lett 643:218318. https:\/\/doi.org\/10.1016\/j.canlet.2026.218318","journal-title":"Cancer Lett"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05694-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:05:31Z","timestamp":1785521131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05694-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5694"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05694-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data from the RISK North database were approved by the Regional Board of Ethics in Ume\u00e5 (2014\/278\u2009\u2212\u200931), and the Swedish Ethical Review Authority (2023-03199-01). Ethical approval for the use of tumor tissue and associated data from a hospital-based biobank of glioblastoma patients, including patient-reported information, was obtained from the Ethics Committee at Ume\u00e5 University (DNR 218\/2003; 2011\/308-31\u00a0M; 2016-200-31; 2021-06594-02). All procedures involving human participants were performed in accordance with the institutional ethical standards and with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the hospital-based cohort. For the population-based register cohort, the use of register data was approved by the relevant ethical review authorities in accordance with Swedish legislation.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"84"}}